These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12077422)

  • 1. Tech.Sight. Antibody design by man and nature.
    Wentworth P
    Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation.
    Wentworth P; McDunn JE; Wentworth AD; Takeuchi C; Nieva J; Jones T; Bautista C; Ruedi JM; Gutierrez A; Janda KD; Babior BM; Eschenmoser A; Lerner RA
    Science; 2002 Dec; 298(5601):2195-9. PubMed ID: 12434011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody catalysis of the oxidation of water.
    Wentworth P; Jones LH; Wentworth AD; Zhu X; Larsen NA; Wilson IA; Xu X; Goddard WA; Janda KD; Eschenmoser A; Lerner RA
    Science; 2001 Sep; 293(5536):1806-11. PubMed ID: 11546867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catalytic antibodies or "abzymes"].
    Lacroix-Desmazes S; Bayry J; Kazatchkine MD; Kaveri SV
    Med Sci (Paris); 2003 May; 19(5):519-22. PubMed ID: 12836378
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology. Catalytic antibody bridges innate and adaptive immunity.
    Nathan C
    Science; 2002 Dec; 298(5601):2143-4. PubMed ID: 12481124
    [No Abstract]   [Full Text] [Related]  

  • 6. Completing the circle.
    Schultz PG; Lerner RA
    Nature; 2002 Aug; 418(6897):485. PubMed ID: 12152057
    [No Abstract]   [Full Text] [Related]  

  • 7. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for the design of catalytic antibodies.
    Janda KD
    Biotechnol Prog; 1990; 6(3):178-81. PubMed ID: 1366610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a real time H2O2 monitor for use in studies on H2O2 production by antibodies and cells.
    Sharma HA; Balcavage WX; Waite LR; Johnson MT; Nindl G
    Biomed Sci Instrum; 2003; 39():554-60. PubMed ID: 12724951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
    Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA
    J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibody-catalyzed water oxidation pathway--a new chemical arm to immune defense?
    Nieva J; Wentworth P
    Trends Biochem Sci; 2004 May; 29(5):274-8. PubMed ID: 15130564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway.
    Nieva J; Kerwin L; Wentworth AD; Lerner RA; Wentworth P
    Immunol Lett; 2006 Feb; 103(1):33-8. PubMed ID: 16386801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting antibodies as catalysts: potential therapeutic applications.
    Tellier C
    Transfus Clin Biol; 2002 Jan; 9(1):1-8. PubMed ID: 11889895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.